AT2 receptor signaling and sympathetic regulation

Research output: Contribution to journalReview article

46 Citations (Scopus)

Abstract

There is a growing consensus that the balance between Angiotensin Type 1 (AT1R) and Angiotensin Type 2 (AT2R) signaling in many tissues may determine the magnitude and, in some cases the direction, of the biological response. Sympatho-excitation in cardiovascular diseases is mediated by a variety of factors and is, in part, dependent on Angiotensin II signaling in the central nervous system. Recent data have provided evidence that the AT2R can modulate sympatho-excitation in animals with hypertension and heart failure. The evidence for this concept is reviewed and a model is put forward to support the rationale that therapeutic targeting of the central AT2R may be beneficial in the setting of chronic heart failure.

Original languageEnglish (US)
Pages (from-to)124-130
Number of pages7
JournalCurrent Opinion in Pharmacology
Volume11
Issue number2
DOIs
StatePublished - Apr 2011

Fingerprint

Angiotensins
Heart Failure
Angiotensin II
Cardiovascular Diseases
Central Nervous System
Hypertension
Therapeutics
Direction compound

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

AT2 receptor signaling and sympathetic regulation. / Gao, Lie; Zucker, Irving H.

In: Current Opinion in Pharmacology, Vol. 11, No. 2, 04.2011, p. 124-130.

Research output: Contribution to journalReview article

@article{e2342ef8a30048dbb6894abfa3dee8da,
title = "AT2 receptor signaling and sympathetic regulation",
abstract = "There is a growing consensus that the balance between Angiotensin Type 1 (AT1R) and Angiotensin Type 2 (AT2R) signaling in many tissues may determine the magnitude and, in some cases the direction, of the biological response. Sympatho-excitation in cardiovascular diseases is mediated by a variety of factors and is, in part, dependent on Angiotensin II signaling in the central nervous system. Recent data have provided evidence that the AT2R can modulate sympatho-excitation in animals with hypertension and heart failure. The evidence for this concept is reviewed and a model is put forward to support the rationale that therapeutic targeting of the central AT2R may be beneficial in the setting of chronic heart failure.",
author = "Lie Gao and Zucker, {Irving H}",
year = "2011",
month = "4",
doi = "10.1016/j.coph.2010.11.004",
language = "English (US)",
volume = "11",
pages = "124--130",
journal = "Current Opinion in Pharmacology",
issn = "1471-4892",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - AT2 receptor signaling and sympathetic regulation

AU - Gao, Lie

AU - Zucker, Irving H

PY - 2011/4

Y1 - 2011/4

N2 - There is a growing consensus that the balance between Angiotensin Type 1 (AT1R) and Angiotensin Type 2 (AT2R) signaling in many tissues may determine the magnitude and, in some cases the direction, of the biological response. Sympatho-excitation in cardiovascular diseases is mediated by a variety of factors and is, in part, dependent on Angiotensin II signaling in the central nervous system. Recent data have provided evidence that the AT2R can modulate sympatho-excitation in animals with hypertension and heart failure. The evidence for this concept is reviewed and a model is put forward to support the rationale that therapeutic targeting of the central AT2R may be beneficial in the setting of chronic heart failure.

AB - There is a growing consensus that the balance between Angiotensin Type 1 (AT1R) and Angiotensin Type 2 (AT2R) signaling in many tissues may determine the magnitude and, in some cases the direction, of the biological response. Sympatho-excitation in cardiovascular diseases is mediated by a variety of factors and is, in part, dependent on Angiotensin II signaling in the central nervous system. Recent data have provided evidence that the AT2R can modulate sympatho-excitation in animals with hypertension and heart failure. The evidence for this concept is reviewed and a model is put forward to support the rationale that therapeutic targeting of the central AT2R may be beneficial in the setting of chronic heart failure.

UR - http://www.scopus.com/inward/record.url?scp=79954420898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954420898&partnerID=8YFLogxK

U2 - 10.1016/j.coph.2010.11.004

DO - 10.1016/j.coph.2010.11.004

M3 - Review article

C2 - 21159555

AN - SCOPUS:79954420898

VL - 11

SP - 124

EP - 130

JO - Current Opinion in Pharmacology

JF - Current Opinion in Pharmacology

SN - 1471-4892

IS - 2

ER -